The neuroanatomy and neurochemistry of sleep-wake control
| dc.contributor.author | Gompf, Heinrich S. | |
| dc.contributor.author | Anaclet, Christelle | |
| dc.date | 2022-08-11T08:08:25.000 | |
| dc.date.accessioned | 2022-08-23T15:54:30Z | |
| dc.date.available | 2022-08-23T15:54:30Z | |
| dc.date.issued | 2020-06-01 | |
| dc.date.submitted | 2020-09-11 | |
| dc.identifier.citation | <p>Gompf HS, Anaclet C. The neuroanatomy and neurochemistry of sleep-wake control. Curr Opin Physiol. 2020 Jun;15:143-151. doi: 10.1016/j.cophys.2019.12.012. Epub 2019 Dec 31. PMID: 32647777; PMCID: PMC7347132. <a href="https://doi.org/10.1016/j.cophys.2019.12.012">Link to article on publisher's site</a></p> | |
| dc.identifier.issn | 2468-8673 (Linking) | |
| dc.identifier.doi | 10.1016/j.cophys.2019.12.012 | |
| dc.identifier.pmid | 32647777 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/29567 | |
| dc.description.abstract | Sleep-wake control is dependent upon multiple brain areas widely distributed throughout the neural axis. Historically, the monoaminergic and cholinergic neurons of the ascending arousal system were the first to be discovered, and it was only relatively recently that GABAergic and glutamatergic wake- and sleep-promoting populations have been identified. Contemporary advances in molecular-genetic tools have revealed both the complexity and heterogeneity of GABAergic NREM sleep-promoting neurons as well as REM sleep-regulating populations in the brainstem such as glutamatergic neurons in the sublaterodorsal nucleus. The sleep-wake cycle progresses from periods of wakefulness to non-rapid eye movement (NREM) sleep and subsequently rapid eye movement (REM) sleep. Each vigilance stage is controlled by multiple neuronal populations, via a complex regulation that is still incompletely understood. In recent years the field has seen a proliferation in the identification and characterization of new neuronal populations involved in sleep-wake control thanks to newer, more powerful molecular genetic tools that are able to reveal neurophysiological functions via selective activation, inhibition and lesion of neuroanatomically defined sub-types of neurons that are widespread in the brain, such as GABAergic and glutamatergic neurons. | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32647777&dopt=Abstract">Link to Article in PubMed</a></p> | |
| dc.relation.url | https://doi.org/10.1016/j.cophys.2019.12.012 | |
| dc.subject | basal forebrain | |
| dc.subject | dorsal raphe | |
| dc.subject | lateral hypothalamus | |
| dc.subject | laterodorsal and pedunculopontine tegmental nuclei | |
| dc.subject | locus coeruleus | |
| dc.subject | nucleus accumbens | |
| dc.subject | parabrachial nucleus | |
| dc.subject | parafacial zone | |
| dc.subject | rostromedial tegmental nucleus | |
| dc.subject | sleep-wake circuitry | |
| dc.subject | sublaterodorsal nucleus | |
| dc.subject | tuberomamillary nucleus | |
| dc.subject | ventral medulla | |
| dc.subject | ventral tegmental area | |
| dc.subject | ventrolateral periaqueductal gray | |
| dc.subject | ventrolateral preoptic area | |
| dc.subject | zona incerta | |
| dc.subject | Cellular and Molecular Physiology | |
| dc.subject | Neuroscience and Neurobiology | |
| dc.title | The neuroanatomy and neurochemistry of sleep-wake control | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Current opinion in physiology | |
| dc.source.volume | 15 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/faculty_pubs/1788 | |
| dc.identifier.contextkey | 19345862 | |
| html.description.abstract | <p>Sleep-wake control is dependent upon multiple brain areas widely distributed throughout the neural axis. Historically, the monoaminergic and cholinergic neurons of the ascending arousal system were the first to be discovered, and it was only relatively recently that GABAergic and glutamatergic wake- and sleep-promoting populations have been identified. Contemporary advances in molecular-genetic tools have revealed both the complexity and heterogeneity of GABAergic NREM sleep-promoting neurons as well as REM sleep-regulating populations in the brainstem such as glutamatergic neurons in the sublaterodorsal nucleus. The sleep-wake cycle progresses from periods of wakefulness to non-rapid eye movement (NREM) sleep and subsequently rapid eye movement (REM) sleep. Each vigilance stage is controlled by multiple neuronal populations, via a complex regulation that is still incompletely understood. In recent years the field has seen a proliferation in the identification and characterization of new neuronal populations involved in sleep-wake control thanks to newer, more powerful molecular genetic tools that are able to reveal neurophysiological functions via selective activation, inhibition and lesion of neuroanatomically defined sub-types of neurons that are widespread in the brain, such as GABAergic and glutamatergic neurons.</p> | |
| dc.identifier.submissionpath | faculty_pubs/1788 | |
| dc.contributor.department | Anaclet Lab | |
| dc.contributor.department | Neurobiology | |
| dc.source.pages | 143-151 |
Files in this item
Name:
Publisher version
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Integrated Analysis of miRNA/mRNA Expression in the Neurocircuitry Underlying Nicotine DependenceNicotine dependence is responsible for perpetuating the adverse health effects due to tobacco use, the leading cause of preventable death worldwide. Nicotine is an agonist for nicotinic acetylcholine receptors, which are enriched in the mesocorticolimbic and habenulo-interpeduncular circuitries, underlying nicotine reward and withdrawal, respectively. Drugs of abuse, including nicotine, induce stable neuroadaptations, requiring protein synthesis through regulation of transcription factors, epigenetic mechanisms, and non-coding RNAs. It also been shown that miRNAs in brain are regulated by nicotine and that miRNA dysregulation contributes to brain dysfunction, including drug addiction. While much is known about the neurocircuitry responsible for the behaviors associated with nicotine reward or withdrawal, the underlying molecular mechanisms of how these changes in behavior are induced are less clear. Using miRNA-/mRNA-Seq, we demonstrate that there are widespread changes in both miRNA and mRNA expression in brain regions comprising the mesocorticolimbic circuit after chronic nicotine treatment, and the habenulo-interpeduncular circuit during acute nicotine withdrawal. Conserved, differentially expressed miRNAs were predicted to target inversely regulated mRNAs. We determined that expression of miR-106b-5p is up-regulated and Profilin 2 (Pfn2), an actin-binding protein enriched in the brain, is down-regulated in the interpeduncular nucleus (IPN) during acute nicotine withdrawal. Further we show that miR-106b-5p represses Pfn2 expression. We demonstrate that knockdown of Pfn2 in the IPN is sufficient to induce anxiety, a symptom of withdrawal. This novel role of Pfn2 in nicotine withdrawal-associated anxiety is a prime example of this dataset’s utility, allowing for the identification of a multitude of miRNAs/mRNA which may participate in the molecular mechanisms underlying the neuroadaptations of nicotine dependence.
-
Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformationThe kinase Mnk2 is a substrate of the MAPK pathway and phosphorylates the translation initiation factor eIF4E. In humans, MKNK2, the gene encoding for Mnk2, is alternatively spliced yielding two splicing isoforms with differing last exons: Mnk2a, which contains a MAPK-binding domain, and Mnk2b, which lacks it. We found that the Mnk2a isoform is downregulated in breast, lung, and colon tumors and is tumor suppressive. Mnk2a directly interacts with, phosphorylates, activates, and translocates p38alpha-MAPK into the nucleus, leading to activation of its target genes, increasing cell death and suppression of Ras-induced transformation. Alternatively, Mnk2b is pro-oncogenic and does not activate p38-MAPK, while still enhancing eIF4E phosphorylation. We further show that Mnk2a colocalization with p38alpha-MAPK in the nucleus is both required and sufficient for its tumor-suppressive activity. Thus, Mnk2a downregulation by alternative splicing is a tumor suppressor mechanism that is lost in some breast, lung, and colon tumors.
-
DNA-damage-induced nuclear export of precursor microRNAs is regulated by the ATM-AKT pathwayExpression of microRNAs (miRNAs) involves transcription of miRNA genes and maturation of the primary transcripts. Recent studies have shown that posttranscriptional processing of primary and precursor miRNAs is induced after DNA damage through regulatory RNA-binding proteins in the Drosha and Dicer complexes, such as DDX5 and KSRP. However, little is known about the regulation of nuclear export of pre-miRNAs in the DNA-damage response, a critical step in miRNA maturation. Here, we show that nuclear export of pre-miRNAs is accelerated after DNA damage in an ATM-dependent manner. The ATM-activated AKT kinase phosphorylates Nup153, a key component of the nucleopore, leading to enhanced interaction between Nup153 and Exportin-5 (XPO5) and increased nuclear export of pre-miRNAs. These findings define an important role of DNA-damage signaling in miRNA transport and maturation.
